It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Novo and Lilly also market their GLP-1s for weight loss under, respectively, Wegovy (semaglutide) and Zepbound (tirzepatide). "In most countries, especially in low-income and middle-income countries, ...

Thank you for standing by. My name is John, and I’ll be your conference operator today. At this time I would like to welcome everyone to the Allurion Third Quarter Earnings Call. All lines have been ...

(Cerullo, 11/13) The Hill: Ozempic And Wegovy May Help With Alcohol Addiction The weight loss drugs ... Hers is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

The dramatic weight loss of several Hollywood celebrities in ... come down”, hinting that the current frenzy around GLP-1s may subside, leaving manufacturers to strike a careful balance between ...

US equities overcame brief spells of volatility to reach new all-time highs in Q3 as underlying earnings growth remained positive. Read more here.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

A 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a ...